{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:59:01Z","timestamp":1759971541072,"version":"build-2065373602"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Bioinform."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Triple-negative breast cancer (TNBC), a classic subtype of breast cancer, is challenging to treat due to the lack of drug-targeting receptors. This study aims to explore interferon-related prognostic molecular biomarkers in TNBC and their potential competing endogenous RNA (ceRNA) regulatory network in TNBC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>RNA expression profiles and interferon genes were downloaded from the Cancer Genome Atlas (TCGA) database and the Gene Set Enrichment Analysis (GSEA) website, respectively. Univariate and multivariate Cox regression analyses were performed to identify prognostic genes and construct a risk model. Single-sample GSEA (ssGSEA) and the CellMiner database were used to explore the relationships between prognostic genes and both tumor immune microenvironment and drug sensitivity, respectively. The lncRNA-miRNA-mRNA network associated with prognosis was constructed using the ENCORI database. Finally, the potential interferon-associated lncRNA\/miRNA\/mRNA regulatory axis was identified through correlation analysis. The abnormal expressions of prognostic genes were validated in three TNBC tumor cell lines compared to normal mammary epithelial cells by using quantitative real-time polymerase chain reaction (qRT-PCR).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The TNBC prognostic signature comprising four interferon genes (STXBP1, LAMP3, CD276, and POLR2F) was identified, with their expression significantly correlated with the infiltration abundance of multiple immune cells and the drug sensitivity of 30 diverse drugs (ARQ-680, Fluphenazine, and Chelerythrine, etc.). Furthermore, an interferon-related genes prognostic ceRNA network was further constructed, consisting of 248 lncRNAs, 66 miRNAs, and 4 mRNAs. As a result, 5 interferon-related ceRNA regulatory axes (AC124067.4\/hsa-miR-455-3p\/STXBP1, RBPMS-AS1\/hsa-miR-455-3p\/STXBP1, DNMBP-AS1\/hsa-miR-455-3p\/STXBP1, FAM198B-AS1\/hsa-miR-455-3p\/STXBP1, LIFR-AS1\/hsa-miR-455-3p\/STXBP1) associated with TNBC progression were identified. QRT-PCR results showed that all four prognostic mRNAs were upregulated in TNBC cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study established a prognostic signature and a ceRNA network associated with interferon in TNBC, and identified five key regulatory axes. In the prognostic signature and the ceRNA axes, STXBP1, RBPMS-AS1, and FAM198B-AS1 were first reported as potential biomarkers of TNBC. These findings have the potential to provide new insights into the mechanisms driving TNBC tumorigenesis and development.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fbinf.2025.1629526","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T14:56:51Z","timestamp":1759935411000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Unveiling the impact of interferon genes on the immune microenvironment of triple-negative breast cancer: identification of therapeutic targets"],"prefix":"10.3389","volume":"5","author":[{"given":"Ying","family":"Liu","sequence":"first","affiliation":[]},{"given":"Jiayi","family":"Cai","sequence":"additional","affiliation":[]},{"given":"Aamir","family":"Fahira","sequence":"additional","affiliation":[]},{"given":"Kai","family":"Zhuang","sequence":"additional","affiliation":[]},{"given":"Jiaojiao","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Zhi","family":"Zhang","sequence":"additional","affiliation":[]},{"given":"Lin","family":"Yan","sequence":"additional","affiliation":[]},{"given":"Yong","family":"Liu","sequence":"additional","affiliation":[]},{"given":"Defang","family":"Ouyang","sequence":"additional","affiliation":[]},{"given":"Zunnan","family":"Huang","sequence":"additional","affiliation":[]}],"member":"1965","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"118241","DOI":"10.1016\/j.biopha.2025.118241","article-title":"Multifaceted interactions between lncRNA-associated ceRNA networks and small molecules in triple-negative breast cancer","volume":"189","author":"Alkan","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"B2","doi-asserted-by":"publisher","first-page":"836417","DOI":"10.3389\/fmolb.2022.836417","article-title":"Triple-negative breast cancer: a brief review about epidemiology, risk factors, signaling pathways, treatment and role of artificial intelligence","volume":"9","author":"Almansour","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"B4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13073-017-0424-2","article-title":"Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden","volume":"9","author":"Chalmers","year":"2017","journal-title":"Genome Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.4110\/in.2025.25.e8","article-title":"Interferon-driven metabolic reprogramming and tumor microenvironment remodeling","volume":"25","author":"Chang","year":"2025","journal-title":"Immune Netw."},{"key":"B6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.soc.2017.08.004","article-title":"Triple-Negative breast cancer: who should receive neoadjuvant chemotherapy?","volume":"27","author":"Chaudhary","year":"2018","journal-title":"Surg. Oncol. Clin. N. Am."},{"key":"B7","doi-asserted-by":"publisher","first-page":"880387","DOI":"10.3389\/fgene.2022.880387","article-title":"Amino acid metabolism-related lncRNA signature predicts the prognosis of breast cancer","volume":"13","author":"Dai","year":"2022","journal-title":"Front. Genet."},{"key":"B8","doi-asserted-by":"publisher","first-page":"13792","DOI":"10.1073\/pnas.1713728114","article-title":"Interferon-beta represses cancer stem cell properties in triple-negative breast cancer","volume":"114","author":"Doherty","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s44276-025-00128-3","article-title":"A novel multigene panel (Sig27) robustly predicts poor prognosis of renal cell carcinoma via high-level associations with immunosuppressive features","volume":"3","author":"Dong","year":"2025","journal-title":"BJC Rep."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1007\/s00345-018-2553-7","article-title":"The development of interferon-based gene therapy for BCG unresponsive bladder cancer: from bench to bedside","volume":"37","author":"Duplisea","year":"2019","journal-title":"World J. Urol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13073-020-0721-z","article-title":"Large-scale public data reuse to model immunotherapy response and resistance","volume":"12","author":"Fu","year":"2020","journal-title":"Genome Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"621809","DOI":"10.3389\/fgene.2021.621809","article-title":"Comprehensive analysis of lncRNA and miRNA regulatory network reveals potential prognostic non-coding RNA involved in breast cancer progression","volume":"12","author":"Gao","year":"2021","journal-title":"Front. Genet."},{"key":"B13","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1007\/s11864-023-01069-0","article-title":"Immunotherapy for metastatic triple negative breast cancer: current paradigm and future approaches","volume":"24","author":"Geurts","year":"2023","journal-title":"Curr. Treat. Options Oncol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"vkaf131","DOI":"10.1093\/jimmun\/vkaf131","article-title":"STING agonists drive recruitment and intrinsic type I interferon responses in monocytic lineage cells for optimal anti-tumor immunity","volume":"9","author":"Girard","year":"2025","journal-title":"J. Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinforma."},{"key":"B16","doi-asserted-by":"publisher","first-page":"23968","DOI":"10.1038\/s41598-025-07855-0","article-title":"Catechin suppresses HNSC via STXBP1 dependent inhibition of macrophage infiltration and CD47 mediated immune evasion","volume":"15","author":"Hao","year":"2025","journal-title":"Sci. Rep."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.21037\/jgo-24-384","article-title":"B7-H3 enhances colorectal cancer progression by regulating HB-EGF via HIF-1\u03b1","volume":"15","author":"Hu","year":"2024","journal-title":"J. Gastrointest. Oncol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"474","DOI":"10.37349\/etat.2023.00146","article-title":"Type 1 and type 2 cytokine-mediated immune orchestration in the tumour microenvironment and their therapeutic potential","volume":"4","author":"Jou","year":"2023","journal-title":"Explor Target Antitumor Ther."},{"key":"B20","doi-asserted-by":"publisher","first-page":"479","DOI":"10.6004\/jnccn.2020.7554","article-title":"Role of immunotherapy in triple-negative breast cancer","volume":"18","author":"Keenan","year":"2020","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","article-title":"Global patterns and trends in breast cancer incidence and mortality across 185 countries","volume":"31","author":"Kim","year":"2025","journal-title":"Nat. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/emmm.201100142","article-title":"IL-28A (IFN-\u03bb2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease","volume":"3","author":"Koltsida","year":"2011","journal-title":"EMBO Mol. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"887380","DOI":"10.3389\/fimmu.2022.887380","article-title":"Cancer associated fibroblasts - an impediment to effective anti-cancer T cell immunity","volume":"13","author":"Koppensteiner","year":"2022","journal-title":"Front. Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 blockade in tumors with mismatch-repair deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e105792","DOI":"10.1371\/journal.pone.0105792","article-title":"Relationships between signaling pathway usage and sensitivity to a pathway inhibitor: examination of trametinib responses in cultured breast cancer lines","volume":"9","author":"Leung","year":"2014","journal-title":"PLoS One"},{"key":"B26","doi-asserted-by":"publisher","first-page":"D92","DOI":"10.1093\/nar\/gkt1248","article-title":"starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data","volume":"42","author":"Li","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"19455","DOI":"10.18632\/oncotarget.14307","article-title":"MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e937126","DOI":"10.12659\/msm.937126","article-title":"Porphyromonas gingivalis activation of tumor-associated macrophages via DOK3 promotes recurrence of oral squamous cell carcinoma","volume":"28","author":"Li","year":"2022","journal-title":"Med. Sci. Monit."},{"key":"B29","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12935-022-02536-8","article-title":"LRP11-AS1 promotes the proliferation and migration of triple negative breast cancer cells via the miR-149-3p\/NRP2 axis","volume":"22","author":"Li","year":"2022","journal-title":"Cancer Cell Int."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e1199","DOI":"10.1002\/ctm2.1199","article-title":"Mature dendritic cells enriched in immunoregulatory molecules (mregDCs): a novel population in the tumour microenvironment and immunotherapy target","volume":"13","author":"Li","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","article-title":"Molecular signatures database (MSigDB) 3.0","volume":"27","author":"Liberzon","year":"2011","journal-title":"Bioinformatics"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.2147\/jhc.S469529","article-title":"CD276 promotes an inhibitory tumor microenvironment in hepatocellular carcinoma and is associated with poor prognosis","volume":"11","author":"Liu","year":"2024","journal-title":"J. Hepatocell. Carcinoma"},{"key":"B33","doi-asserted-by":"publisher","first-page":"7061","DOI":"10.2147\/cmar.S260150","article-title":"Construction and comprehensive analysis of a ceRNA network to reveal potential novel biomarkers for triple-negative breast cancer","volume":"12","author":"Ma","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"102117","DOI":"10.1016\/j.tranon.2024.102117","article-title":"Excavating regulated cell death signatures to predict prognosis, tumor microenvironment and therapeutic response in HR+\/HER2-breast cancer","volume":"50","author":"Mao","year":"2024","journal-title":"Transl. Oncol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1260498","DOI":"10.3389\/fimmu.2023.1260498","article-title":"Interferon gene therapy with nadofaragene firadenovec for bladder cancer: from bench to approval","volume":"14","author":"Martini","year":"2023","journal-title":"Front. Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/cei\/uxac078","article-title":"Regulatory T-cell therapy approaches","volume":"211","author":"McCallion","year":"2023","journal-title":"Clin. Exp. Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1902880","DOI":"10.1002\/advs.201902880","article-title":"ImmuCellAI: a unique method for comprehensive T-Cell subsets abundance prediction and its application in cancer immunotherapy","volume":"7","author":"Miao","year":"2020","journal-title":"Adv. Sci. (Weinh)"},{"key":"B38","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1002\/cncr.25938","article-title":"Hypoxic regulation and prognostic value of LAMP3 expression in breast cancer","volume":"117","author":"Nagelkerke","year":"2011","journal-title":"Cancer"},{"key":"B39","doi-asserted-by":"publisher","first-page":"6154","DOI":"10.1002\/jcb.27903","article-title":"Integrated network analysis and machine learning approach for the identification of key genes of triple-negative breast cancer","volume":"120","author":"Naorem","year":"2019","journal-title":"J. Cell Biochem."},{"key":"B40","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s43018-022-00339-4","article-title":"LCOR mediates interferon-independent tumor immunogenicity and responsiveness to immune-checkpoint blockade in triple-negative breast cancer","volume":"3","author":"P\u00e9rez-N\u00fa\u00f1ez","year":"2022","journal-title":"Nat. Cancer"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1158\/0008-5472.Can-12-1370","article-title":"CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set","volume":"72","author":"Reinhold","year":"2012","journal-title":"Cancer Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","article-title":"A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?","volume":"146","author":"Salmena","year":"2011","journal-title":"Cell"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e10832","DOI":"10.1016\/j.heliyon.2022.e10832","article-title":"Construction of novel lncRNA-miRNA-mRNA ceRNA networks associated with prognosis of hepatitis C virus related hepatocellular carcinoma","volume":"8","author":"Shao","year":"2022","journal-title":"Heliyon"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e010782","DOI":"10.1136\/jitc-2024-010782","article-title":"UBE2T\/CDC42\/CD276 signaling axis mediates brain metastasis of triple-negative breast cancer via lysosomal autophagy","volume":"13","author":"Shi","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"B45","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1136\/bmj.286.6367.739","article-title":"Interferon and cancer","volume":"286","author":"Sikora","year":"1983","journal-title":"Br. Med. J. Clin. Res. Ed."},{"key":"B46","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s40425-016-0165-6","article-title":"Clinical significance of tumor-infiltrating lymphocytes in breast cancer","volume":"4","author":"Stanton","year":"2016","journal-title":"J. Immunother. Cancer"},{"key":"B47","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e01456-22","DOI":"10.1128\/jvi.01456-22","article-title":"Upregulation of ATF4-LAMP3 axis by ORF45 facilitates lytic replication of Kaposi's sarcoma-associated herpesvirus","volume":"96","author":"Sun","year":"2022","journal-title":"J. Virol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/s43018-020-0038-2","article-title":"Bystander IFN-\u03b3 activity promotes widespread and sustained cytokine signaling altering the tumor microenvironment","volume":"1","author":"Thibaut","year":"2020","journal-title":"Nat. Cancer"},{"key":"B50","doi-asserted-by":"publisher","first-page":"A68","DOI":"10.5114\/wo.2014.47136","article-title":"The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge","volume":"19","author":"Tomczak","year":"2015","journal-title":"Contemp. Oncol. Pozn."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1661194","DOI":"10.1080\/2162402x.2019.1661194","article-title":"Low CD4+\/CD25+\/CD127- regulatory T cell- and high INF-\u03b3 levels are associated with improved survival of neuroblastoma patients treated with long-term infusion of ch14.18\/CHO combined with interleukin-2","volume":"8","author":"Troschke-Meurer","year":"2019","journal-title":"Oncoimmunology"},{"key":"B52","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3389\/fmed.2017.00227","article-title":"Tumor heterogeneity in breast cancer","volume":"4","author":"Turashvili","year":"2017","journal-title":"Front. Med. (Lausanne)"},{"key":"B53","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1039\/c5mb00700c","article-title":"Identifying the crosstalk of dysfunctional pathways mediated by lncRNAs in breast cancer subtypes","volume":"12","author":"Wang","year":"2016","journal-title":"Mol. Biosyst."},{"key":"B55","doi-asserted-by":"publisher","first-page":"e008983","DOI":"10.1136\/jitc-2024-008983","article-title":"Interactions between LAMP3+ dendritic cells and T-cell subpopulations promote immune evasion in papillary thyroid carcinoma","volume":"12","author":"Wang","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.3390\/life13061310","article-title":"The immunotherapeutic role of type I and III interferons in Melanoma and Non-Melanoma skin cancers","volume":"13","author":"Weir","year":"2023","journal-title":"Life (Basel)"},{"key":"B57","doi-asserted-by":"publisher","first-page":"856560","DOI":"10.3389\/fonc.2022.856560","article-title":"The LINC01929\/miR-6875-5p\/ADAMTS12 axis in the ceRNA network regulates the development of advanced bladder cancer","volume":"12","author":"Xiong","year":"2022","journal-title":"Front. Oncol."},{"key":"B58","first-page":"459","article-title":"Repositioning antipsychotic fluphenazine hydrochloride for treating triple negative breast cancer with brain metastases and lung metastases","volume":"9","author":"Xu","year":"2019","journal-title":"Am. J. Cancer Res."},{"key":"B59","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.bbrc.2020.11.118","article-title":"T-bet transduction enhances anti-tumor efficacy of IFN-producing dendritic cell (IKDC) against hepatocellular carcinoma via apoptosis induction","volume":"535","author":"Xu","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B60","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1093\/bib\/bbu002","article-title":"An assessment of computational methods for estimating purity and clonality using genomic data derived from heterogeneous tumor tissue samples","volume":"16","author":"Yadav","year":"2015","journal-title":"Brief. Bioinform"},{"key":"B61","doi-asserted-by":"publisher","first-page":"e70040","DOI":"10.1111\/1756-185x.70040","article-title":"V\u03b36(+)\u03b3\u03b4T cells participate in lupus nephritis in MRL\/Lpr mice","volume":"28","author":"Yan","year":"2025","journal-title":"Int. J. Rheum. Dis."},{"key":"B62","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/s41419-021-04006-x","article-title":"Melatonin inhibits triple-negative breast cancer progression through the Lnc049808-FUNDC1 pathway","volume":"12","author":"Yang","year":"2021","journal-title":"Cell Death Dis."},{"key":"B63","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1038\/s41467-019-11415-2","article-title":"Comprehensive transcriptomic analysis of cell lines as models of primary tumors across 22 tumor types","volume":"10","author":"Yu","year":"2019","journal-title":"Nat. Commun."},{"key":"B64","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1186\/s12885-019-5983-8","article-title":"Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue","volume":"19","author":"Zhou","year":"2019","journal-title":"BMC Cancer"}],"container-title":["Frontiers in Bioinformatics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbinf.2025.1629526\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T14:56:52Z","timestamp":1759935412000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbinf.2025.1629526\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":64,"alternative-id":["10.3389\/fbinf.2025.1629526"],"URL":"https:\/\/doi.org\/10.3389\/fbinf.2025.1629526","relation":{},"ISSN":["2673-7647"],"issn-type":[{"value":"2673-7647","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]},"article-number":"1629526"}}